Literature DB >> 8082296

Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).

E L Malchiodi1, M G Chiaramonte, N J Taranto, N W Zwirner, R A Margni.   

Abstract

Results of our studies on the reactivity of chagasic and leishmaniasic sera with the purified T. cruzi-specific antigen 163B6, as assessed by ELISA, and with complex antigenic mixtures from T. cruzi and Leishmania mexicana, by immunoblotting, are presented here. Our objective was to identify the antigens responsible for the exhibited cross-reactivity between trypanosomiasis and leishmaniasis, and to find a specific reactivity pattern corresponding to each parasitosis. In spite of the high cross-reactivity observed with the immunoblotting, the use of 7.5% A-B gels made it possible to identify a characteristic pattern for each parasitosis, that could be distinguished by the naked eye. The characteristic pattern corresponding to chagasic patients was ascribed to reactivity with T. cruzi bands of mol. wts 131, 125, 116, 111, 51-45 and 43 kD, that were not recognized by leishmaniasic sera. Trypanosoma cruzi antigens of mol. wts 85, 81, 70, 65-60, 37 and 32 kD were considered as crossing antigens, since they were recognized by leishmaniasis sera. With L. mexicana, most of the chagasic patients presented reaction with antigen of mol. wts 124, 107, 92, 59 and 32 kD, while bands of mol. wts 155, 140, 73, 56 and 48 kD were recognized only by leishmaniasic sera. In this study we found 12 out of 45 sera of patients with leishmaniasis, from a region endemic for both parasitoses, which exhibited a pattern of bands very similar to those corresponding to chagasic individuals, strongly suggesting a mixed infection. This hypothesis was verified by using a purified specific antigen of T. cruzi, Ag163B6, which would be the major cysteine proteinase of this specie (cruzipain). By ELISA, these 12 sera showed a positive reaction with this purified antigen, as those of chagasic patients, thus leading to the confirmation of the presence of a mixed infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082296      PMCID: PMC1534865          DOI: 10.1111/j.1365-2249.1994.tb06104.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi.

Authors:  E Bontempi; J J Cazzulo
Journal:  FEMS Microbiol Lett       Date:  1990-08       Impact factor: 2.742

2.  Isolation-characterization and preliminary immunological studies of a Trypanosoma cruzi antigenic component.

Authors:  E L Malchiodi; C H Carbonetto; R A Margni
Journal:  Medicina (B Aires)       Date:  1987       Impact factor: 0.653

3.  Isolation of a Trypanosoma cruzi antigen by affinity chromatography with a monoclonal antibody. Preliminary evaluation of its possible applications in serological tests.

Authors:  C H Carbonetto; E L Malchiodi; M Chiaramonte; E Durante de Isola; C A Fossati; R A Margni
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Identification and analysis of epimastigote surface and metabolic proteins in Trypanosoma cruzi.

Authors:  J P McDaniel; R J Howard; J A Dvorak
Journal:  Mol Biochem Parasitol       Date:  1986-05       Impact factor: 1.759

5.  Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis.

Authors:  C L Jaffe; M Zalis
Journal:  Mol Biochem Parasitol       Date:  1988-01-01       Impact factor: 1.759

6.  IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.

Authors:  T M Chiller; M A Samudio; G Zoulek
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

7.  The 70-kDa heat-shock protein is a major antigenic determinant in human Trypanosoma cruzi/Leishmania braziliensis braziliensis mixed infection.

Authors:  P Levy Yeyati; S Bonnefoy; G Mirkin; A Debrabant; S Lafon; A Panebra; E Gonzalez-Cappa; J P Dedet; M Hontebeyrie-Joskowicz; M J Levin
Journal:  Immunol Lett       Date:  1992-01       Impact factor: 3.685

8.  Use of purified parasite proteins from Leishmania donovani for the rapid serodiagnosis of visceral leishmaniasis.

Authors:  C L Jaffe; M Zalis
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

9.  The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.

Authors:  J Martinez; O Campetella; A C Frasch; J J Cazzulo
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction.

Authors:  T Souto-Padrón; O E Campetella; J J Cazzulo; W de Souza
Journal:  J Cell Sci       Date:  1990-07       Impact factor: 5.285

View more
  22 in total

1.  Identification of a Western blot pattern for the specific diagnosis of Trypanosoma cruzi infection in human sera.

Authors:  Cristina Riera; Mireia Verges; Laura Iniesta; Roser Fisa; Montserrat Gállego; Silvia Tebar; Montserrat Portús
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.

Authors:  Vera Lucia Pereira-Chioccola; Abilio Augusto Fragata-Filho; Antonio Marcos de Apparecida Levy; Mauricio M Rodrigues; Sergio Schenkman
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

3.  Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis.

Authors:  Jamyra Iglesias Cataldo; Fernanda Carvalho de Queiroz Mello; Eliame Mouta-Confort; Maria de Fátima Madeira; Armando de Oliveira Schubach; Marcelo da Silva Genestra; Flávia Coelho Ribeiro; Célia de Fátima Moreira-Venâncio; Sônia Regina Lambert Passos
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.

Authors:  Natacha Cerny; Andrés Sánchez Alberti; Augusto E Bivona; Mauricio C De Marzi; Fernanda M Frank; Silvia I Cazorla; Emilio L Malchiodi
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

5.  Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.

Authors:  M E Brito; M G Mendonça; Y M Gomes; M L Jardim; F G Abath
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

6.  Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.

Authors:  Silvia I Cazorla; Pablo D Becker; Fernanda M Frank; Thomas Ebensen; María J Sartori; Ricardo S Corral; Emilio L Malchiodi; Carlos A Guzmán
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

7.  Serological diagnosis of Chagas' disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi.

Authors:  R P Mendes; S Hoshino-Shimizu; A M Moura da Silva; I Mota; R A Heredia; A O Luquetti; P G Leser
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

8.  Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.

Authors:  Mariana C Duarte; Daniel C Pimenta; Daniel Menezes-Souza; Rubens D M Magalhães; João L C P Diniz; Lourena E Costa; Miguel A Chávez-Fumagalli; Paula S Lage; Daniela C Bartholomeu; Maria Julia M Alves; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Denise U Gonçalves; Manoel O C Rocha; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

9.  Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.

Authors:  F D Cordeiro; O A Martins-Filho; M O Da Costa Rocha; S J Adad; R Corrêa-Oliveira; A J Romanha
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

10.  Detection and characterization of antigens in urine of patients with acute, congenital, and chronic Chagas' disease.

Authors:  R S Corral; J Altcheh; S R Alexandre; S Grinstein; H Freilij; A M Katzin
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.